Cost-effectiveness analysis of colorectal cancer screening with stool DNA testing in intermediate-incidence countries

[1]  C. Ko,et al.  Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging. , 2005, Journal of the National Cancer Institute.

[2]  J. Ferlay,et al.  Global Cancer Statistics, 2002 , 2005, CA: a cancer journal for clinicians.

[3]  D. Ransohoff,et al.  Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population. , 2004, The New England journal of medicine.

[4]  J. Faivre,et al.  Reduction in colorectal cancer mortality by fecal occult blood screening in a French controlled study. , 2004, Gastroenterology.

[5]  A. Fendrick,et al.  Fecal DNA testing compared with conventional colorectal cancer screening methods: a decision analysis. , 2004, Gastroenterology.

[6]  M. Leshno,et al.  Cost-Effectiveness of Colorectal Cancer Screening in the Average Risk Population , 2003, Health care management science.

[7]  M. Lawson,et al.  Sensitivity and specificity of a stool DNA multitarget assay panel for the detection of advanced colorectal neoplasia. , 2003, Clinical colorectal cancer.

[8]  S. Woolf,et al.  Colorectal cancer screening and surveillance: clinical guidelines and rationale-Update based on new evidence. , 2003, Gastroenterology.

[9]  L. Holmberg,et al.  Compliance and findings in a Swedish population screened for colorectal cancer with sigmoidoscopy. , 2002, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[10]  Hermann Brenner,et al.  Cost-effectiveness of colonoscopy in screening for colorectal cancer. , 2002, Archives of internal medicine.

[11]  M. Koshiji,et al.  Microsatellite analysis of fecal DNA for colorectal cancer detection * , 2002, Journal of surgical oncology.

[12]  K. Kinzler,et al.  Detection of APC mutations in fecal DNA from patients with colorectal tumors. , 2002, The New England journal of medicine.

[13]  R. Hayward,et al.  Which colon cancer screening test? A comparison of costs, effectiveness, and compliance. , 2001, The American journal of medicine.

[14]  S. Goodman,et al.  Detecting colorectal cancer in stool with the use of multiple genetic targets. , 2001, Journal of the National Cancer Institute.

[15]  J. Faivre,et al.  Estimation of screening test (Hemoccult®) sensitivity in colorectal cancer mass screening , 2001, British Journal of Cancer.

[16]  S. Thibodeau,et al.  Colorectal cancer screening by detection of altered human DNA in stool: feasibility of a multitarget assay panel. , 2000, Gastroenterology.

[17]  L. Tabár,et al.  Estimation of Sojourn Time in Chronic Disease Screening Without Data on Interval Cases , 2000, Biometrics.

[18]  T. Prevost,et al.  Evaluation of a selective screening for colorectal carcinoma , 1999, Cancer.

[19]  S. Moss,et al.  Interval cancers in a randomized controlled trial of screening for colorectal cancer using a faecal occult blood test. , 1999, International journal of epidemiology.

[20]  J. Faivre,et al.  Colonoscopic screening in first-degree relatives of patients with 'sporadic' colorectal cancer: a case-control study. The Association Nationale des Gastroentérologues des Hôpitaux and Registre Bourguignon des Cancers Digestifs (INSERM CRI 9505) , 1998, Gastroenterology.

[21]  J. Cummings,et al.  Quantitation of DNA from exfoliated colonocytes isolated from human stool surface as a novel noninvasive screening test for colorectal cancer. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[22]  D. Gyrd-Hansen,et al.  Analysis of screening data: colorectal cancer. , 1997, International journal of epidemiology.

[23]  S. Duffy,et al.  Colorectal cancer mass‐screening: Estimation of faecal occult blood test sensitivity, taking into account cancer mean sojourn time , 1997, International journal of cancer.

[24]  S. Vernon,et al.  Participation in colorectal cancer screening: a review. , 1997, Journal of the National Cancer Institute.

[25]  D. Ahlquist.  Fecal occult blood testing for colorectal cancer. Can we afford to do this? , 1997, Gastroenterology clinics of North America.

[26]  J. Olsen,et al.  Randomised study of screening for colorectal cancer with faecal-occult-blood test , 1996, The Lancet.

[27]  A. Sonnenberg,et al.  Protection by endoscopy against death from colorectal cancer. A case-control study among veterans. , 1995, Archives of internal medicine.

[28]  L. Tabár,et al.  Estimation of mean sojourn time in breast cancer screening using a Markov chain model of both entry to and exit from the preclinical detectable phase. , 1995, Statistics in medicine.

[29]  S. Ciatto,et al.  Sensitivity of screening sigmoidoscopy for proximal colorectal tumours , 1995, The Lancet.

[30]  D. Rex,et al.  Colonoscopy: a review of its yield for cancers and adenomas by indication. , 1995, The American journal of gastroenterology.

[31]  D. Ershoff,et al.  Do characteristics of adenomas on flexible sigmoidoscopy predict advanced lesions on baseline colonoscopy? , 1994, Gastroenterology.

[32]  D. Ahlquist,et al.  Accuracy of fecal occult blood screening for colorectal neoplasia: A prospective study using Hemoccult and Hemo‐Quant tests , 1993 .

[33]  L M Schuman,et al.  Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. , 1993, The New England journal of medicine.

[34]  H. Wieand,et al.  Accuracy of fecal occult blood screening for colorectal neoplasia. A prospective study using Hemoccult and HemoQuant tests. , 1993, JAMA.

[35]  G. Friedman,et al.  A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. , 1992, The New England journal of medicine.

[36]  J. Reinus,et al.  Flexible sigmoidoscopy may be ineffective for secondary prevention of colorectal cancer in asymptomatic, average-risk men. , 1992, Gastrointestinal endoscopy.

[37]  R. Sampliner,et al.  Prospective blinded trial of the colonoscopic miss-rate of large colorectal polyps. , 1991, Gastrointestinal endoscopy.

[38]  S. Moss,et al.  Randomised controlled trial of faecal-occult-blood screening for colorectal cancer , 1989, The Lancet.

[39]  E. Achkar,et al.  Small polyps found during fiberoptic sigmoidoscopy in asymptomatic patients. , 1988, Annals of internal medicine.

[40]  S. Stryker,et al.  Natural history of untreated colonic polyps. , 1987, Gastroenterology.

[41]  B. Benjamin.  Health and Vital Statistics , 1969 .

[42]  H. D. Miller,et al.  The Theory Of Stochastic Processes , 1977, The Mathematical Gazette.

[43]  文魚 長谷川.  D.R. Cox and H.D. Miller: The Theory of Stochastic Processes, Methuen. London, 1965, 398頁, 24×16cm, 4,200円. , 1966 .

[44]  P. Loehrer.  Colon Cancer Survival Rates With the New American Joint Committee on Cancer Sixth Edition Staging , 2006 .

[45]  Michael Pignone,et al.  Cost-effectiveness analyses of colorectal cancer screening: a systematic review for the U.S. Preventive Services Task Force. , 2002, Annals of internal medicine.

[46]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.

[47]  D. Rex,et al.  Colonoscopic miss rates of adenomas determined by back-to-back colonoscopies. , 1997, Gastroenterology.

[48]  F. V. von Eyben,et al.  Colorectal cancer screening: clinical guidelines and rationale. , 1997, Gastroenterology.

[49]  Robert J. Mayer,et al.  Erratum: Colorectal cancer screening: Clinical guidelines and rationale (Gastroenterology (1997) 112 (594-642)) , 1997 .